Moderna (MRNA) Treasury Shares (2017 - 2025)

Moderna (MRNA) has 8 years of Treasury Shares data on file, last reported at $11.2 million in Q4 2025.

• On a quarterly basis, Treasury Shares rose 42.49% year-over-year to $11.2 million in Q4 2025; TTM through Dec 2025 was $11.2 million, a 42.49% increase from a year earlier, with the FY2025 full-year figure at $11.2 million, up 42.49% from the prior year.
• Treasury Shares for Q4 2025 stood at $11.2 million, up from $7.9 million in the prior quarter.
• Over the last five years, Treasury Shares for MRNA reached as high as $11.2 million in Q4 2025 and fell as low as $2.1 million in Q4 2021.
• Historically, Treasury Shares has averaged $4.5 million across 5 years, with a median of $2.6 million in 2021.
• Across the five-year window, Treasury Shares decreased 2.28% in 2021 and jumped 78.62% in 2023, its largest moves.
• Year by year, Treasury Shares stood at $2.1 million in 2021, then soared by 35.51% to $2.9 million in 2022, then soared by 78.62% to $5.2 million in 2023, then surged by 51.74% to $7.9 million in 2024, then jumped by 42.49% to $11.2 million in 2025.
• Per Business Quant data, the three most recent Treasury Shares figures were $11.2 million in Q4 2025, $7.9 million in Q4 2024, and $5.2 million in Q4 2023.